UNIQUE EXPERTISE
Headquartered in Reykjavik, Iceland, deCODE is a global leader in analyzing and understanding the human genome. Using our unique expertise and population resources, deCODE has discovered key genetic risk factors for dozens of common diseases ranging from cardiovascular disease to cancer.
UNIQUE CAPABILITIES
We operate the most productive human gene discovery engine in the world, employing our discoveries to identify genetic variations associated with human disease.
OUR PUBLICATIONS
We regularly publish our discoveries in major, peer-reviewed journals, enabling others to further validate and expand upon our findings.
NEWS
deCODE GENETICS OF ICELAND MAPS A GENE LINKED TO PRE-ECLAMPSIA
Reykjavik, September 19th, 1999 — deCODE genetics, Inc. announced today that they have identified a locus on chromosome 2p13 that contains a gene that is linked to pre-eclampsia in women — a condition that is indicated in an estimated three to seven percent of...
Decode Genetics and Roche Announce Progress in Osteoarthritis Research Program
Reykjavik, Iceland, March 26, 1999 — deCODE genetics and Roche announced today that scientists at deCODE have successfully mapped a gene linked to osteoarthritis to an area on a human chromosome. This finding will focus further efforts aimed at identifying this gene...
Award by the American Society of Human Genetics
At its Annual meeting in October 2017 in Orlando, the American Society of Human Genetics (ASHG), presented Dr. Kári Stefánsson, founder and CEO of deCODE genetics, with the William Allan Award. The award, the top prize given by the society, recognizes a scientist for substantial and far-reaching scientific contributions to human genetics. The ASHG has distributed video footage from the award ceremony. The introduction is given by Professor Mark Daly of Harvard University.